AXQ Capital’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

AXQ Capital’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-83,330	Closed	-$205K	–	1149
2026 Q1	$205K	Buy	+83,330	New	+$279K	0.03%	739

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AIHC Capital Management Central $104M AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AXQ Capital's NBP Position: Q2 2026 in Review

AXQ Capital sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2026, closing a stake of 83,330 shares — an estimated $205K sold.

AXQ Capital first reported a position in NBP in Q1 2026 and held it in 1 quarter. The position peaked at $205K in Q1 2026. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

AXQ Capital reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2026 after selling out during the quarter.
AXQ Capital sold 83,330 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $205K.
AXQ Capital first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2026 and held it in 1 quarter.
AXQ Capital's NovaBridge Biosciences American Depositary Shares position peaked at $205K in Q1 2026.
49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.